Novavax Nuvaxovid(TM) COVID-19 Vaccine Conditionally Authorize...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., July 6, 2022 /PRNewswire-AsiaNet/ -- -- Nuvaxovid(TM) COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 in EuropeNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for seri...
Authors: LATEST ASIANET NEWS RELEASES